-page 3, paragraph 3 under the "Interventions" section, the reference to Table 1 was deleted from the text -page 4, first paragraph under the "Comparisons" section, BZN was replaced with BZN/60CD and NFX was replaced with NFX/120HD -page 5, the reference to Figure 2 was replaced with Table 2 within the text -page 6, first paragraph, 1st line, under the "Laboratory testing" section, "Outcome date" should read "Efficacy outcome data" and "the outcome when they are processed" on the 6th line should read "the efficacy outcome when they are processed"
-page 7: --the reference to Table 2 was replaced with  Table 3 --first paragraph, 4th line, under the "Randomisation" section, the text "of similar aspect, whose content is unknown" was deleted --first paragraph, 4th line, under the "Discussion" section, "Most of these trials with relatively little data" should read "Most with relatively little data" -In both figures of the manuscript, referring to the study drugs, the short forms used for Benznidazole (BZD) were different from what is used throughout the manuscript (BZN). The BZN for is kept. Table 3 was added to the manuscript -The name of Additional file 2 was changed from "The undersigned president of the ethics board for clinical research at the fundacion oftalmologica de santander foscal" to "Ethics board approval, Fundación Oftalmológica de Santander (english version certificate)" -The acknowledgment for Nicolas' Gelvez contribution to the manuscript was moved to the end of the "Acknowlegments" section
The original article has been corrected.
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